Literature DB >> 35530274

Pyroptosis impacts the prognosis and treatment response in gastric cancer via immune system modulation.

Wanli Yang1, Liaoran Niu1, Xinhui Zhao2, Lili Duan1, Xiaoqian Wang1, Yiding Li1, Junfeng Chen1, Wei Zhou1, Yujie Zhang3, Daiming Fan1, Liu Hong1.   

Abstract

Pyroptosis plays a vital role in the development of cancers; however, its role in regulating immune cell infiltration in tumor microenvironment (TME) and pyroptosis-related molecular subtypes remain unclear. Herein, we comprehensively analyzed the molecular subtypes mediated by the pyroptosis-related genes (PRGs) in gastric cancer (GC). Three pyroptosis patterns were determined with distinct TME cell-infiltrating characteristics and prognosis. Principal component analysis was performed to establish the pyroptosis score. The high pyroptosis score group was featured by increased activated CD4+ T cell infiltration, better prognosis, elevated tumor mutation burden, higher immune and stromal scores, and enhanced response to immunotherapy. However, the low pyroptosis score group was characterized by poorer survival, decreased immune infiltration, and glycerolipid and histidine metabolism pathways. Additionally, high pyroptosis score was confirmed as an independent favorable prognostic factor for overall survival. Three cohorts designed to analyze the response to immunotherapy verified that patients with higher pyroptosis score showed treatment benefit. In summary, our study demonstrated that pyroptosis regulates the complex TME. Assessing the pyroptosis patterns will advance our understanding on TME features and tumor immunology and provide the rationale for designing personalized immunotherapy strategies. AJCR
Copyright © 2022.

Entities:  

Keywords:  Pyroptosis; gastric cancer; immunotherapy; prognosis; tumor microenvironment

Year:  2022        PMID: 35530274      PMCID: PMC9077078     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  63 in total

Review 1.  Cancer immunotherapy: accomplishments to date and future promise.

Authors:  Karim Y Helmy; Shyam A Patel; George R Nahas; Pranela Rameshwar
Journal:  Ther Deliv       Date:  2013-10

Review 2.  The Tumor Microenvironment Innately Modulates Cancer Progression.

Authors:  Dominique C Hinshaw; Lalita A Shevde
Journal:  Cancer Res       Date:  2019-07-26       Impact factor: 12.701

3.  Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy.

Authors:  Franziska Blaeschke; Milan Cedric Paul; Martin Ulrich Schuhmann; Armin Rabsteyn; Christopher Schroeder; Nicolas Casadei; Jakob Matthes; Christopher Mohr; Ramin Lotfi; Beate Wagner; Theresa Kaeuferle; Judith Feucht; Semjon Willier; Rupert Handgretinger; Stefan StevanoviĆ; Peter Lang; Tobias Feuchtinger
Journal:  Cytotherapy       Date:  2019-07-25       Impact factor: 5.414

4.  Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.

Authors:  Sabina Signoretti; Catherine J Wu; Sachet A Shukla; Toni K Choueiri; David A Braun; Yue Hou; Ziad Bakouny; Miriam Ficial; Miriam Sant' Angelo; Juliet Forman; Petra Ross-Macdonald; Ashton C Berger; Opeyemi A Jegede; Liudmilla Elagina; John Steinharter; Maxine Sun; Megan Wind-Rotolo; Jean-Christophe Pignon; Andrew D Cherniack; Lee Lichtenstein; Donna Neuberg; Paul Catalano; Gordon J Freeman; Arlene H Sharpe; David F McDermott; Eliezer M Van Allen
Journal:  Nat Med       Date:  2020-05-29       Impact factor: 53.440

5.  Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.

Authors:  Pornpimol Charoentong; Francesca Finotello; Mihaela Angelova; Clemens Mayer; Mirjana Efremova; Dietmar Rieder; Hubert Hackl; Zlatko Trajanoski
Journal:  Cell Rep       Date:  2017-01-03       Impact factor: 9.423

Review 6.  Immunotherapy for gastric cancer: dilemmas and prospect.

Authors:  Qingfang Zhao; Liang Cao; Lulu Guan; Liangyu Bie; Saiqi Wang; Bojian Xie; Xiaobing Chen; Xiaokun Shen; Feiling Cao
Journal:  Brief Funct Genomics       Date:  2019-03-22       Impact factor: 4.241

7.  Gasdermin D Exerts Anti-inflammatory Effects by Promoting Neutrophil Death.

Authors:  Hiroto Kambara; Fei Liu; Xiaoyu Zhang; Peng Liu; Besnik Bajrami; Yan Teng; Li Zhao; Shiyi Zhou; Hongbo Yu; Weidong Zhou; Leslie E Silberstein; Tao Cheng; Mingzhe Han; Yuanfu Xu; Hongbo R Luo
Journal:  Cell Rep       Date:  2018-03-13       Impact factor: 9.423

8.  DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.

Authors:  Hyunchul Jung; Hong Sook Kim; Jeong Yeon Kim; Jong-Mu Sun; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Manel Esteller; Se-Hoon Lee; Jung Kyoon Choi
Journal:  Nat Commun       Date:  2019-09-19       Impact factor: 14.919

9.  m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer.

Authors:  Wei Chong; Liang Shang; Jin Liu; Zhen Fang; Fengying Du; Hao Wu; Yang Liu; Zhe Wang; Yang Chen; Shengtao Jia; Liming Chen; Leping Li; Hao Chen
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

View more
  1 in total

1.  A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer.

Authors:  Dao Xin; Yuxin Man; Yalan Yang; Feng Wang
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.